Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 8, 2025
Castle Biosciences Strengthens Commitment to Esophageal Cancer Awareness Through Collaborative Partnerships
GlobeNewswire
·
April 8, 2025
FRIENDSWOOD, Texas, April 08, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, is supporting key educational programs and initiatives throughout the month of …
Koryx Copper Provides Update on Zambia Projects and Planned 2025 Exploration Work Program
GlobeNewswire
·
April 8, 2025
Highlights Koryx Copper owns 51% of two highly prospective exploration licenses in the Zambian copper belt, with an option to earn up to 80% over the next 30 months. Over the last few months significant work was completed in preparation for the …
Algernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease
GlobeNewswire
·
April 8, 2025
VANCOUVER, British Columbia, April 08, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce …
Aya Gold & Silver Reports High-Grade Drill Results at Boumadine, Extends Tizi Zone to 2.2km and Identifies New Regional Targets
GlobeNewswire
·
April 8, 2025
MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce new high-grade drill exploration results from its 2024 - 2025 program at Boumadine in the Kingdom of Morocco. …
Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA
GlobeNewswire
·
April 8, 2025
FDA action allows for unrestricted distribution of EGRIFTA SV®, removing uncertainty with respect to all manufactured batches PAS approval follows recent FDA approval of new formulation, EGRIFTA WR™ MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- …
Forsys Reports Positive Ore Sorting Testwork at Norasa
GlobeNewswire
·
April 8, 2025
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) Forsys is pleased to report on ore-sorting testwork at its Norasa Uranium project (“Norasa”1). Highlights Exploratory ore sorting …
Cartesian Therapeutics’ Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial
GlobeNewswire
·
April 8, 2025
After a single course of therapy, Descartes-08-treated participants were observed to sustain deep responses through long-term follow-up, with an average 4.8-point reduction in MG-ADL at Month 12 Deepest and most compelling sustained responses observed in …
Routine medical appointments and cancer screenings head in the wrong direction
GlobeNewswire
·
April 8, 2025
ALEXANDRIA, Va., April 08, 2025 (GLOBE NEWSWIRE) -- When was the last time you saw your doctor? There’s been a change in how often U.S. adults are going to routine medical appointments and cancer screenings, and according to the Prevent Cancer Foundation’s …
Aya Or & Argent publie des résultats de forage à haute teneur à Boumadine, augmente l’étendue de la zone Tizi à 2,2 km et identifie de nouvelles cibles régionales
GlobeNewswire
·
April 8, 2025
MONTRÉAL, 08 avr. 2025 (GLOBE NEWSWIRE) -- Aya Or & Argent Inc. (TSX : AYA; OTCQX : AYASF) (« Aya » ou la « Société ») a le plaisir d’annoncer de nouveaux résultats de forage d’exploration à haute teneur issus de son programme 2024-2025 à Boumadine dans le …
Tilray Brands Reports Q3 Fiscal 2025 Financial Results
GlobeNewswire
·
April 8, 2025
Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. …
Theratechnologies reçoit l’approbation de la FDA pour le supplément d’approbation préalable [PAS] relatif à sa demande d’un supplément à la licence de produit biologique (sBLA) pour EGRIFTA SV(MD)
GlobeNewswire
·
April 8, 2025
L’approbation de la FDA permet une distribution sans restriction d’EGRIFTA SVMD, levant ainsi l'incertitude concernant tous les lots fabriqués L’approbation du PAS fait suite à l’approbation récente de la nouvelle formulation, EGRIFTA WRMC MONTRÉAL, 08 avr …
EV Charging Station Market size to hit USD 355.33 Billion By 2032, at a Booming CAGR of 40.2%, says Coherent Market Insights
GlobeNewswire
·
April 8, 2025
Burlingame, CA, April 08, 2025 (GLOBE NEWSWIRE) -- Increasing adoption of electric vehicles (EVs) driven by environmental concerns and government incentives Drives EV Charging Station Market Growth from USD 33.36 Bn in 2025 Get a Sample Report of EV …
Federal Leaders Endorse Streamlined Permitting Process for Mining Projects
GlobeNewswire
·
April 8, 2025
Prime Minister of Canada supports “one project, one review” approval process Official Leader of the Opposition names Troilus as project of interest to accelerate resource development MONTREAL, April 08, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (TSX: TLG …
Les Dirigeants Fédéraux Appuient Un Processus D’autorisation Simplifié Pour Les Projets Miniers
GlobeNewswire
·
April 8, 2025
Le premier ministre du Canada appuie un processus d’approbation de type « un projet, une évaluation » Le chef de l’opposition officielle désigne Troilus comme projet d’intérêt pour accélérer le développement des ressources MONTREAL, 08 avr. 2025 (GLOBE …
Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders
GlobeNewswire
·
April 8, 2025
Vancouver, Canada, April 08, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Shoqan School, founded by Kenges Rakishev and Aselle Tasmagambetova, places three Kazakhstan Students at Harvard and UC Berkeley in the first year of its Mentorship Program
GlobeNewswire
·
April 8, 2025
ALMATY, Kazakhstan, April 08, 2025 (GLOBE NEWSWIRE) -- Three students from Shoqan Walikhanov School in Almaty have been admitted to Harvard University and UC Berkeley in the first year of a Mentorship Program established by the school’s founders, Kenges …
Telix Announces Cardinal Health for Gozellix Commercial Distribution
GlobeNewswire
·
April 8, 2025
MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its …
Cybersecurity Career Resilience: Certs + Experience = Success
GlobeNewswire
·
April 8, 2025
Cary, NC, April 08, 2025 (GLOBE NEWSWIRE) -- Cybersecurity professionals are facing unprecedented market volatility and shifting employer demands. INE Security, a global leader in cybersecurity training and certifications, is offering new insight into how …
N2OFF Announces Potential to Maximize Investment Opportunity Following New Regulation in Germany
GlobeNewswire
·
April 8, 2025
New German regulation, Section 8a of the Renewable Energy Sources Act – EEG, allows expanded use of grid infrastructure, enabling high-value battery storage addition to flagship renewable energy site Neve Yarak, Israel, April 08, 2025 (GLOBE NEWSWIRE) -- …
GC Brieau accélère son virage vers l'intelligence artificielle avec des investissements majeurs!
GlobeNewswire
·
April 8, 2025
SHERBROOKE, Québec, 08 avr. 2025 (GLOBE NEWSWIRE) -- GC Brieau, fournisseur de services informatiques gérés de premier plan dans la région de l'Estrie, annonce aujourd'hui des investissements majeurs dans l'intelligence artificielle, marquant ainsi une …